These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Olanzapine and NMS. Hickey C; Stewart C; Lippmann S Psychiatr Serv; 1999 Jun; 50(6):836-7. PubMed ID: 10375159 [No Abstract] [Full Text] [Related]
12. Provocation of obsessive-compulsive behaviour and tremor by olanzapine. al-Mulhim A; Atwal S; Coupland NJ Can J Psychiatry; 1998 Aug; 43(6):645. PubMed ID: 9729696 [No Abstract] [Full Text] [Related]
13. Neuroleptic malignant syndrome associated with olanzapine therapy. Apple JE; Van Hauer G Psychosomatics; 1999; 40(3):267-8. PubMed ID: 10341541 [No Abstract] [Full Text] [Related]
14. Reduction of tardive dystonia with olanzapine. Jaffe ME; Simpson GM Am J Psychiatry; 1999 Dec; 156(12):2016. PubMed ID: 10588425 [No Abstract] [Full Text] [Related]
15. Olanzapine motor side effect. Daniel DG; Egan M; Issa F Neuropsychopharmacology; 1997 Jan; 16(1):88-90. PubMed ID: 8981393 [No Abstract] [Full Text] [Related]
17. Paranoia and agitation associated with olanzapine treatment. al Jeshi A Can J Psychiatry; 1998 Mar; 43(2):195. PubMed ID: 9533976 [No Abstract] [Full Text] [Related]
18. Mania associated with olanzapine. London JA J Am Acad Child Adolesc Psychiatry; 1998 Feb; 37(2):135-6. PubMed ID: 9473906 [No Abstract] [Full Text] [Related]
19. Olanzapine: a new typical antipsychotic drug. Meltzer HY; Fibiger HC Neuropsychopharmacology; 1996 Feb; 14(2):83-5. PubMed ID: 8822530 [No Abstract] [Full Text] [Related]
20. Experiences with clozapine and olanzapine. Chatterton R Aust N Z J Psychiatry; 1998 Jun; 32(3):463. PubMed ID: 9672741 [No Abstract] [Full Text] [Related] [Next] [New Search]